oxaliplatin - Generic mfg.
Rituxan (rituximab) - Roche
paclitaxel - Generic mfg.
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Comparison of infusion-related reactions to chemotherapy versus targeted therapy: A four-year experience at the Medical Day Hospital of the Fondazione IRCCS Istituto Nazionale Tumori Milano. (PubMed, Tumori) - Oct 1, 2026 - "Chemotherapy remains associated with a significantly higher risk of IRs compared to targeted therapies. Although clinical presentations are similar, distinct pathophysiological mechanisms require tailored management and risk assessment." 
Journal • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/42811683
 
Chiara Cavalli; Federica Manoni; Gabriella Mariani; Katia Fiorella Dotti; Laura Anna Maria Ferrari; Valentino Ippocrates Redaelli
 
Oct 1, 2026
 
Prev Next